Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
Smith
K J
KJ
Vidmar
D
D
Skelton
H G
HG
Hackley
B E
BE
D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002396:Catechols / Q000627:therapeutic use; D016207:Cytokines / Q000276:immunology; D017449:Dermatitis, Allergic Contact / Q000276:immunology; D004137:Dinitrochlorobenzene / Q000276:immunology / Q000627:therapeutic use*; D015658:HIV Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007167:Immunotherapy; D007509:Irritants / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D008466:Mechlorethamine / Q000276:immunology / Q000627:therapeutic use; D010947:Plants, Toxic; D012882:Skin Tests; D018417:Th1 Cells / Q000276:immunology; D012251:Toxicodendron
D002396:Catechols; D016207:Cytokines; D004137:Dinitrochlorobenzene; D007509:Irritants; D008466:Mechlorethamine; C003747:urushiol